Union Bancaire Privee’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26M Buy
174,631
+6,334
+4% +$166K 0.07% 156
2026
Q1
$5.66M Buy
168,297
+6,367
+4% +$170K 0.08% 144
2025
Q4
$5.03M Buy
161,930
+26,490
+20% +$668K 0.06% 147
2025
Q3
$4.32M Buy
135,440
+5,494
+4% +$136K 0.06% 140
2025
Q2
$2.75M Sell
129,946
-56,036
-30% -$1.31M 0.04% 164
2025
Q1
$4.43M Buy
185,982
+20,053
+12% +$525K 0.09% 102
2024
Q4
$4.32M Buy
+165,929
New +$4.5M 0.08% 114

Other funds holding PFE

Union Bancaire Privee's PFE Position: Q2 2026 in Review

Union Bancaire Privee increased its Pfizer (PFE) stake by 3.8% in Q2 2026, buying an estimated $166K and bringing the position to 174,631 shares worth $6.26M. The position accounts for 0.07% of the portfolio, ranked #156.

Union Bancaire Privee first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Union Bancaire Privee held 174,631 shares of Pfizer worth $6.26M as of Q2 2026.
  • Union Bancaire Privee bought 6,334 Pfizer shares in Q2 2026, an estimated $166K.
  • Pfizer made up 0.07% of Union Bancaire Privee's portfolio in Q2 2026, its #156 holding.
  • Union Bancaire Privee first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.